CA2652558A1 - Souches bacteriennes, compositions les contenant et utilisation probiotique de ces souches - Google Patents

Souches bacteriennes, compositions les contenant et utilisation probiotique de ces souches Download PDF

Info

Publication number
CA2652558A1
CA2652558A1 CA002652558A CA2652558A CA2652558A1 CA 2652558 A1 CA2652558 A1 CA 2652558A1 CA 002652558 A CA002652558 A CA 002652558A CA 2652558 A CA2652558 A CA 2652558A CA 2652558 A1 CA2652558 A1 CA 2652558A1
Authority
CA
Canada
Prior art keywords
coli
dna
bacterial
composition
database
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002652558A
Other languages
English (en)
Inventor
Andrew K. Benson
Robert A. Hoerr
Eileen F. Bostwick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
BioBalance LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioBalance LLC filed Critical BioBalance LLC
Publication of CA2652558A1 publication Critical patent/CA2652558A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
CA002652558A 2006-05-18 2007-05-09 Souches bacteriennes, compositions les contenant et utilisation probiotique de ces souches Abandoned CA2652558A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80109806P 2006-05-18 2006-05-18
US60/801,098 2006-05-18
PCT/US2007/011200 WO2007136553A2 (fr) 2006-05-18 2007-05-09 Souches bactériennes, compositions les contenant et utilisation probiotique de ces souches

Publications (1)

Publication Number Publication Date
CA2652558A1 true CA2652558A1 (fr) 2007-11-29

Family

ID=38647934

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002652558A Abandoned CA2652558A1 (fr) 2006-05-18 2007-05-09 Souches bacteriennes, compositions les contenant et utilisation probiotique de ces souches

Country Status (4)

Country Link
EP (1) EP2035544A2 (fr)
JP (1) JP2009537138A (fr)
CA (1) CA2652558A1 (fr)
WO (1) WO2007136553A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1913787B (zh) 2004-02-03 2014-11-26 增值研究合伙有限公司 在动物中促进生长的活体细菌的应用
WO2007079147A2 (fr) 2005-12-28 2007-07-12 Advanced Bionutrition Corporation Véhicule de délivrance pour bactéries probiotiques, comprenant une matrice sèche en polysaccharides, saccharides et polyols sous forme de verre, et son procédé de préparation
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
EP2117354B1 (fr) 2006-12-18 2018-08-08 Advanced BioNutrition Corp. Produit alimentaire sec contenant un probiotique vivant
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
GB0922467D0 (en) * 2009-04-24 2010-02-03 Danisco Feed supplement
EP2435554B1 (fr) 2009-05-26 2017-07-26 Advanced Bionutrition Corporation Composition de poudre sèche stable comprenant des micro-organismes biologiquement actifs et/ou des matériaux bioactifs et procédés de fabrication
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
US8834951B2 (en) 2010-01-28 2014-09-16 Advanced Bionutrition Corporation Dry glassy composition comprising a bioactive material
DK2603100T3 (en) 2010-08-13 2018-08-06 Advanced Bionutrition Corp DRY STABILIZING COMPOSITION FOR STORAGE OF BIOLOGICAL MATERIALS
EP2463382A1 (fr) 2010-12-07 2012-06-13 Enterologics, Inc. Procédé d'identification de E. Coli M-17
CN102653779B (zh) * 2011-03-04 2014-02-19 北京科润三联生物技术有限责任公司 一种新型重组抗菌多肽药物的制备方法
KR101794242B1 (ko) * 2011-06-07 2017-11-07 임병갑 서방성 경구용 액상 제제
WO2013006960A1 (fr) * 2011-07-13 2013-01-17 Foodchek Systems, Inc. Milieu de culture, procédé de culture de listeria et procédé de détection de listeria
CN103131724B (zh) * 2011-11-25 2015-02-25 畿晋庆三联（北京）生物技术有限公司 一种高效表达工程菌重组蛋白的方法及应用
DK3628161T3 (da) * 2012-11-23 2023-05-30 Seres Therapeutics Inc Synergistiske bakterielle sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
WO2014121304A1 (fr) 2013-02-04 2014-08-07 Seres Health, Inc. Compositions et procédés
JP2016509003A (ja) 2013-02-04 2016-03-24 セレス セラピューティクス インコーポレイテッド 組成物および方法
JP2016519664A (ja) 2013-03-15 2016-07-07 セレス セラピューティクス インコーポレイテッド ネットワークを基にした微生物組成物及び方法
KR102515850B1 (ko) 2013-11-25 2023-03-30 세레스 테라퓨틱스, 인코포레이티드 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
MY194231A (en) 2015-07-29 2022-11-23 Advanced Bionutrition Corp Stable dry probiotic compositions for special dietary uses
AU2018318132A1 (en) 2017-08-14 2020-02-27 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
JP7252606B2 (ja) * 2019-03-25 2023-04-05 国立研究開発法人農業・食品産業技術総合研究機構 乳酸菌検出プライマーセットおよび該プライマーセットを用いた検出方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use

Also Published As

Publication number Publication date
WO2007136553A2 (fr) 2007-11-29
EP2035544A2 (fr) 2009-03-18
WO2007136553A3 (fr) 2008-01-31
JP2009537138A (ja) 2009-10-29

Similar Documents

Publication Publication Date Title
CA2652558A1 (fr) Souches bacteriennes, compositions les contenant et utilisation probiotique de ces souches
US11458174B2 (en) Synergistic bacterial compositions and methods of production and use thereof
Rozman et al. Characterization of antimicrobial resistance in lactobacilli and bifidobacteria used as probiotics or starter cultures based on integration of phenotypic and in silico data
US10610549B2 (en) Composition comprising bacterial strains
Rosander et al. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938
JP2021059545A (ja) 相乗作用のある細菌組成物ならびにその製造及び使用方法
RU2664479C2 (ru) Композиции и способы
Pérez et al. Diarrheagenic Escherichia coli in children from Costa Rica
KR20210100662A (ko) 박테리아를 안정화시키는 조성물 그리고 이의 용도
Orth et al. Prevalence, structure and expression of urease genes in Shiga toxin-producing Escherichia coli from humans and the environment
Bajorek et al. B. infantis EVC001 is well-tolerated and improves human milk oligosaccharide utilization in preterm infants in the neonatal intensive care unit
El‐Sharoud et al. Molecular characterisation and stress tolerance of E scherichia coli isolated from dairy and dried milk‐related products
Sato et al. Development of strain-specific PCR primers for quantitative detection of Bacillus mesentericus strain TO-A in human feces
Abdulmajeed et al. Isolation and Identification of E. Coli O157: H7 Strains Among Diarrheal Sample in Relation with the Presence of Stx1, Stx2, Hlya and Eaea Genes
Konstantinov Lactobacilli in the porcine intestine: from composition to functionality
Jayaweera et al. Prevalence of Salmonella Pathogenisity Island (SPI1, SPI2, SPI3 and SPI5) Genes in Salmonella species Isolated from fresh Broiler Chicken Meat in Sri Lanka.
WO2024062208A1 (fr) Compositions et méthodes de réduction du sulfure endogène chez des patients atteints de maladies inflammatoires de l'intestin
Abed et al. Detection of Diarrhoeagenic Escherichia Coli Among Other Bacterial Species Isolated from Children Patients by Automated Methods and Culture based Techniques
AU2022348603A1 (en) Biotherapeutic enterococcus isolates
Tu et al. Genomic characteristics of the Campylobacter fetus sap island
Munns Characterization of Escherichia coli O157: H7 from super-shedding feedlot cattle
Lienemann Foodborne human isolates of Salmonella and Shiga toxin-producing Escherichia coli of domestic origin in Finland
Temmerman Culture-dependent and culture-independent microbial analysis of probiotics
Boyle et al. 31 Safety Assessment of Probiotics
Pino et al. Lactobacillus rhamnosus GG supplementation in Systemic Nickel allergy Syndrome patients

Legal Events

Date Code Title Description
FZDE Dead